Targeted nanoparticles for cancer therapy

Frank X. Gu, Rohit Karnik, Andrew Z. Wang, Frank Alexis, Etgar Levy-Nissenbaum, Seungpyo Hong, Robert S. Langer, Omid C. Farokhzad

Research output: Contribution to journalArticle

414 Citations (Scopus)

Abstract

Over the past decade, there has been an increasing interest in using nanotechnology for cancer therapy. The development of smart targeted nanoparticles (NPs) that can deliver drugs at a sustained rate directly to cancer cells may provide better efficacy and lower toxicity for treating primary and advanced metastatic tumors. We highlight some of the promising classes of targeting molecules that are under development for the delivery of NPs. We also review the emerging technologies for the fabrication of targeted NPs using microfluidic devices.

Original languageEnglish
Pages (from-to)14-21
Number of pages8
JournalNano Today
Volume2
Issue number3
DOIs
Publication statusPublished - 2007 Jun

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering
  • Materials Science(all)
  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'Targeted nanoparticles for cancer therapy'. Together they form a unique fingerprint.

  • Cite this

    Gu, F. X., Karnik, R., Wang, A. Z., Alexis, F., Levy-Nissenbaum, E., Hong, S., Langer, R. S., & Farokhzad, O. C. (2007). Targeted nanoparticles for cancer therapy. Nano Today, 2(3), 14-21. https://doi.org/10.1016/S1748-0132(07)70083-X